ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2015

Abstract Number: 200

Mast Cell Regulation of Aortic IL-6 Expression Involves Histamine-1 Receptor, Suppressor of Cyotkine Signaling-1 and IL-10

Vineesh Raveendran1, Jason Springer2, Donald Smith3, Mehrdad Maz4 and Kottarappat Dileepan1, 1Department of Medicine, University of Kansas Medical Center, Kansas City, KS, 2Division of Allergy, Clinical Immunology and Rheumatology, University of Kansas Medical Center, Kansas City, KS, 3University of Kansas Medical Center, Kansas City, KS, 4Division of Rheumatology, University of Kansas Medical Center, Kansas City, KS

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2015

Date of first publication: September 29, 2015

Keywords: giant cell arteritis, IL-6, interleukins (IL), mast cells and vasculitis

Session Information

Date: Sunday, November 8, 2015

Title: Innate Immunity and Rheumatic Disease Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: IL-6 plays an important role in the pathogenesis of large vessel vasculitis.  Lipopolysaccharide (LPS), acting through toll-like receptor 4, enhances both the aortic expression as well as serum levels of IL-6.  Previous work by our group has demonstrated that systemic mast cell degranulation will inhibit both the serum and aortic expression of IL-6 in LPS injected mice.  Mast cells release many vasoactive substances including histamine, proteases, and IL-10 .  Our hypothesis is that the inhibitory effect of mast cells on aortic IL-6 production is mediated through histamine and/or IL-10.

Methods: Two month-old male C57BI6 (WT) and Histamine 1 Receptor (H1R) -/- mice were randomized into four groups, and given intraperitoneal injections with normal saline (control),  compound 48/80 (mast cell degranulation agent, 1mg/kg), LPS (1mg/kg) or C48/80+LPS.  Mice were sacrificed 24-h later, and levels of the stable metabolites of prostaglandin I2 (PGI2) and thromboxane A2 (TXA2) in the urine, and IL-6 and IL-10 in sera were quantified.

Results: MC degranulation did not increase PGI2 in control or in LPS-treated mice of either genotype. LPS injection increased PGI2 in both genotypes, but the increase was higher in H1R-/- mice. Both C48/80 and LPS increased TXA2 in WT mice, but only LPS treatment enhanced TXA2 in H1R-/-mice indicating importance H1R in this pathway.  Treatment with C48/80 did not further enhance prostanoid production over LPS.  LPS treatment increased serum IL-6 in both genotypes, but the changes were significant only in WT mice.  Interestingly, LPS-induced IL-6 production was significantly reduced by MC degranulation in WT mice, but not in H1R-/- mice.  In WT mice the inhibition of IL-6 was associated with enhanced aortic expression of SOCS1.  In comparison to WT, the basal and induced levels of IL-10 were markedly higher in H1R-/- mice. 

Conclusion: Mast cells differentially regulate LPS-induced inflammatory response in WT and H1R -/- mice.  These results suggest that MCs regulate LPS-induced systemic and aortic inflammatory response involving H1R, SOCS-1 and IL-10.

Acknowledgements: Supported by NIH grants R01-HL070101 & 3R01-HL070101-04S1, the Joseph & Elizabeth Carey Arthritis Fund and Audrey Smith Fund from KU Endowment Association, Lied Grant from KUMC Research Institute, and by the Department of Internal Medicine Research Office. H1R-null breeding pairs were graciously provided by Dr. Cory Teuscher, University of Vermont, Burlington, VT.


Disclosure: V. Raveendran, None; J. Springer, None; D. Smith, None; M. Maz, None; K. Dileepan, None.

To cite this abstract in AMA style:

Raveendran V, Springer J, Smith D, Maz M, Dileepan K. Mast Cell Regulation of Aortic IL-6 Expression Involves Histamine-1 Receptor, Suppressor of Cyotkine Signaling-1 and IL-10 [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/mast-cell-regulation-of-aortic-il-6-expression-involves-histamine-1-receptor-suppressor-of-cyotkine-signaling-1-and-il-10/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mast-cell-regulation-of-aortic-il-6-expression-involves-histamine-1-receptor-suppressor-of-cyotkine-signaling-1-and-il-10/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology